1. Polygonati rhizoma fermentation by Monascus ruber and evaluation of fermentation products in vitro.
- Author
-
Tao, Zijun, Zhang, Jian, Niu, Fuge, Zhang, Huien, Chen, Zhongfa, Wang, Shanfu, Zhang, Yuli, Li, Jie, and Liu, Peng
- Subjects
- *
SOLID-state fermentation , *CYCLIC adenylic acid , *GLUTAMIC acid , *SODIUM cholate , *ANTILIPEMIC agents - Abstract
This study investigated the conditions for polygonati rhizoma (PR) fermentation by Monascus ruber and the lipid-lowering activity of the resulting product. Monascus ruber was used for the solid-state fermentation of PR, and the response surface method was used to optimize the fermentation culture medium parameters. The optimal fermentation system yielded a maximum monacolin K concentration of 21.82 ± 0.34 mg/g. The fermentation conditions were as follows: 12.5 mmol/kg of L-glutamic acid, 0.64 mmol/kg of cyclic adenosine monophosphate, 3.0 wt% of yeast extract powder, a fermentation period of 15 days, and a fermentation temperature of 30 ℃. The binding capacities of unfermented PR, "Nine-Steam-Nine-Bask" processed Polygonati rhizoma (NPR), and Monascus ruber solid-state fermented polygonati rhizoma (MPR) to sodium cholate, sodium taurocholate, and sodium glycolate were determined. MPR showed a stronger bile acid-binding capacity than unfermented PR. In addition, MPR exhibited the highest cholesterol inhibitory capacity of 51.43±1.41 %. Thus, MPR can be used as a potential antilipemic agent with potent hypolipidemic effects. [Display omitted] • Monascus-fermented metabolites may be a potentially anti-hypertensive drug. • culture-medium can promote the production of monacolin K. • Polygonati rhizome has the potential as a hypolipidemic properties. • synergistic effect of Monascus solid state fermented polygonati rhizome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF